FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4307064900> ?p ?o ?g. }

• W4307064900 endingPage "e71" @default.
• W4307064900 startingPage "e70" @default.
• W4307064900 abstract "<h3>Purpose/Objective(s)</h3> Glioblastoma (GBM) is a highly aggressive primary brain tumor. A major challenge in GBM treatment is tumor resistance to radiation and chemotherapy. An important hallmark of GBM is the frequent mutation of epigenetic modifiers resulting in alteration of epigenetic signaling pathways in tumor cells. However, the effect of epigenetic signaling on chemotherapy response in GBM remains to be elucidated. SETD2 is a unique histone methyl transferase that facilitates H3K36 tri-methylation. Here, we unveil the role of SETD2 mutations that frequently occur in GBM in tumor resistance to temozolomide chemotherapy. <h3>Materials/Methods</h3> We have performed next-generation sequencing of the SETD2 gene and immunohistochemical staining if its product H3K36me3 in 129 GBM patient samples that was supplemented with TCGA database analysis of additional 279 GBM samples. We used primary patient-derived GBM lines to investigate the mechanism of chemotherapy resistance in SETD2-mutant GBM. <h3>Results</h3> We demonstrate that inactivating SETD2 mutations occur in up to 13% of GBM patients. Our investigation reveals that SETD2 mutations are associated with reduced progression-free (Median PFS 0.93 vs. 0.44 years, p=0.0022) and overall survival (Median survival 1.69 vs. 1.30 years, p=0.0044) in patients with methylated MGMT (methyl-guanine methyl transferase) promotor who received temozolomide suggesting that mutation of SETD2 is a predictive marker for treatment outcomes in GBM. Consequently, we demonstrate that loss of SETD2 results in reduced H3K36me3 levels in patient samples and a profound resistance to temozolomide in primary patient-derived GBM lines. MGMT-deficient tumors can acquire chemoresistance due to disrupted mismatch repair (MMR), a DNA repair pathway that plays a critical role in converting primary temozolomide-induced DNA lesions into toxic DNA double-strand breaks. Strikingly, we found that SETD2 loss abrogates the expression of the MMR factor MSH6 indicating that chemoresistance in SETD2-deficient cells us due to disrupted MMR. Mechanistically, we show that SETD2 regulates MMR by promoting transcription of the <i>MSH6</i> gene in GBM. Epigenetic modifiers have specific antagonists capable of reversing chromatin alterations induced by these modifiers. This provides a unique opportunity to restore chemotherapy response in SETD2-mutant GBM by targeting the antagonists of SETD2. We demonstrate that combined targeting of H3K36me3-specific histone de-methylases KDM4A and NO66 restores H3K36me3 levels along with MSH6 expression and sensitivity to temozolomide in SETD2-deficient GBM cells. <h3>Conclusion</h3> Our findings establish SETD2 mutation as a novel molecular marker predictive of treatment response in GBM and provide a framework for a novel approach to overcome chemotherapy resistance in this malignant brain tumor by targeting an epigenetic signaling pathway." @default.
• W4307064900 created "2022-10-23" @default.
• W4307064900 creator A5016860693 @default.
• W4307064900 creator A5019731866 @default.
• W4307064900 creator A5029157957 @default.
• W4307064900 creator A5033358988 @default.
• W4307064900 creator A5043341752 @default.
• W4307064900 creator A5076015262 @default.
• W4307064900 date "2022-11-01" @default.
• W4307064900 modified "2023-10-14" @default.
• W4307064900 title "A Novel Epigenetic Marker Predicts Treatment Response in Glioblastoma and Provides a Target for Overcoming Treatment Resistance" @default.
• W4307064900 doi "https://doi.org/10.1016/j.ijrobp.2022.07.828" @default.
• W4307064900 hasPublicationYear "2022" @default.
• W4307064900 type Work @default.
• W4307064900 citedByCount "0" @default.
• W4307064900 crossrefType "journal-article" @default.
• W4307064900 hasAuthorship W4307064900A5016860693 @default.
• W4307064900 hasAuthorship W4307064900A5019731866 @default.
• W4307064900 hasAuthorship W4307064900A5029157957 @default.
• W4307064900 hasAuthorship W4307064900A5033358988 @default.
• W4307064900 hasAuthorship W4307064900A5043341752 @default.
• W4307064900 hasAuthorship W4307064900A5076015262 @default.
• W4307064900 hasConcept C104317684 @default.
• W4307064900 hasConcept C121608353 @default.
• W4307064900 hasConcept C126322002 @default.
• W4307064900 hasConcept C143998085 @default.
• W4307064900 hasConcept C2776694085 @default.
• W4307064900 hasConcept C2776745794 @default.
• W4307064900 hasConcept C2777389519 @default.
• W4307064900 hasConcept C2780521871 @default.
• W4307064900 hasConcept C33288867 @default.
• W4307064900 hasConcept C41091548 @default.
• W4307064900 hasConcept C501734568 @default.
• W4307064900 hasConcept C502942594 @default.
• W4307064900 hasConcept C54355233 @default.
• W4307064900 hasConcept C71924100 @default.
• W4307064900 hasConcept C86803240 @default.
• W4307064900 hasConcept C91965660 @default.
• W4307064900 hasConceptScore W4307064900C104317684 @default.
• W4307064900 hasConceptScore W4307064900C121608353 @default.
• W4307064900 hasConceptScore W4307064900C126322002 @default.
• W4307064900 hasConceptScore W4307064900C143998085 @default.
• W4307064900 hasConceptScore W4307064900C2776694085 @default.
• W4307064900 hasConceptScore W4307064900C2776745794 @default.
• W4307064900 hasConceptScore W4307064900C2777389519 @default.
• W4307064900 hasConceptScore W4307064900C2780521871 @default.
• W4307064900 hasConceptScore W4307064900C33288867 @default.
• W4307064900 hasConceptScore W4307064900C41091548 @default.
• W4307064900 hasConceptScore W4307064900C501734568 @default.
• W4307064900 hasConceptScore W4307064900C502942594 @default.
• W4307064900 hasConceptScore W4307064900C54355233 @default.
• W4307064900 hasConceptScore W4307064900C71924100 @default.
• W4307064900 hasConceptScore W4307064900C86803240 @default.
• W4307064900 hasConceptScore W4307064900C91965660 @default.
• W4307064900 hasIssue "3" @default.
• W4307064900 hasLocation W43070649001 @default.
• W4307064900 hasOpenAccess W4307064900 @default.
• W4307064900 hasPrimaryLocation W43070649001 @default.
• W4307064900 hasRelatedWork W2028367236 @default.
• W4307064900 hasRelatedWork W2129558754 @default.
• W4307064900 hasRelatedWork W2170553105 @default.
• W4307064900 hasRelatedWork W2329655639 @default.
• W4307064900 hasRelatedWork W2333344083 @default.
• W4307064900 hasRelatedWork W2345717877 @default.
• W4307064900 hasRelatedWork W2776406960 @default.
• W4307064900 hasRelatedWork W2947141972 @default.
• W4307064900 hasRelatedWork W4210308948 @default.
• W4307064900 hasRelatedWork W4295013567 @default.
• W4307064900 hasVolume "114" @default.
• W4307064900 isParatext "false" @default.
• W4307064900 isRetracted "false" @default.
• W4307064900 workType "article" @default.